Statistics

Total Visits

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice31

Select a period of time:

Number of views in the range

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice18

Views

Views
November 20240
December 20240
January 20250
February 20250
March 202515
April 20253
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States2
Spain1
 

Top cities views

Views
Council Bluffs1